Companies: 10,795·Total market cap: $144.5T
AVITA Medical, Inc.

AVITA Medical, Inc.

RCELNASDAQHealthcare● Active
$4.21
+$0.05(+1.20%)
Market Cap$104588609
P/E Ratio
52W High$7.12
52W Low$3.22
Overview

AVITA Medical, Inc. (RCEL) Revenue

Annual & quarterly revenue history · segment & region breakdown

RCEL · revenue · updated Jun 9, 2026

Core revenue metrics

AVITA Medical, Inc. trailing twelve-month (TTM) revenue is $0.07B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.07B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
1.43×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$278K
260 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · AVITA Medical, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
RCEL revenue by year · RCEL revenue history · RCEL annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income AVITA Medical, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

AVITA Medical, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from AVITA Medical, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

RCEL revenue · 4 questions

RCEL's trailing twelve-month (TTM) revenue is $0.07B. That is an increase of 0.00% year-over-year from — in FY.

RCEL revenueRCEL annual revenuewhat is RCEL revenueRCEL TTM revenue

Source: FMP · AVITA Medical, Inc. SEC filings · GAAP · AVITA Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026